flavourzyme

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Chiang, Wen-Dee: 1 article (03/2018)
2.	Hung, Tsu-Han: 1 article (03/2018)
3.	Lin, Wan-Teng: 1 article (03/2018)
4.	Marthandam Asokan, Shibu: 1 article (03/2018)
5.	Cheong, Sun Hee: 1 article (11/2013)
6.	Hwang, Jin-Woo: 1 article (11/2013)
7.	Jeon, Byong-Tae: 1 article (11/2013)
8.	Kim, Eun-Kyung: 1 article (11/2013)
9.	Kim, Yon-Suk: 1 article (11/2013)
10.	Lee, Jung-Suck: 1 article (11/2013)

1.	Neuroinflammatory Diseases 12/27/2022 - "In this study, two hemp protein hydrolysate (HPHs), obtained with Alcalase as sole catalyst, or with Alcalase followed by Flavourzyme, were evaluated as inflammatory mediators (TNFα, IL-1β, IL-6, and IL-10), microglial polarization markers (Ccr7, iNos, Arg1, and Ym1), and genes related to inflammasome activation (Nlrp3, Asc, Casp1, and Il18), employing the lipopolysaccharide (LPS)-induced neuroinflammation model in murine BV-2 microglial cells. "
2.	Prostatic Neoplasms (Prostate Cancer) 11/27/2013 - "Flavourzyme hydrolysate, which showed clearly superior cytotoxic activity on prostate cancer cells, was further purified using a membrane system and consecutive chromatographic methods. "
3.	Atrophy 03/01/2018 - "In mouse models that were fed a high fat diet (HFD), a lipolysis-stimulating peptide-VHVV (purified from hydrolysate resulting from flavourzyme treatment of soy protein) was found to reduce HFD-related apoptotic effects in mice skeletal muscle and potentially control atrophy. "

1.	Inflammasomes
2.	Interleukin-18 (Interleukin 18)
3.	Subtilisins (Subtilopeptidase A)
4.	Protein Hydrolysates
5.	Lipopolysaccharides
6.	Soybean Proteins (Soy Protein)
7.	Peptides (Polypeptides)